Insider Transactions in Q4 2025 at Axsome Therapeutics, Inc. (AXSM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Mark E Saad |
SELL
Open market or private sale
|
Direct |
37,577
-57.1%
|
$6,200,205
$165.18 P/Share
|
|
Dec 31
2025
|
Mark E Saad |
BUY
Exercise of conversion of derivative security
|
Direct |
37,577
+35.43%
|
$225,462
$6.49 P/Share
|
|
Dec 04
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,558
-59.36%
|
$1,562,584
$148.18 P/Share
|
|
Dec 04
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,558
+37.25%
|
$84,464
$8.02 P/Share
|
|
Dec 03
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,163
-73.61%
|
$2,943,798
$146.94 P/Share
|
|
Dec 03
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,163
+42.4%
|
$161,304
$8.02 P/Share
|
|
Dec 02
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
49,252
-87.2%
|
$7,092,288
$144.59 P/Share
|
|
Dec 02
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,252
+46.58%
|
$394,016
$8.02 P/Share
|
|
Nov 05
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,775
-75.08%
|
$2,917,850
$134.49 P/Share
|
|
Nov 05
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,775
+42.88%
|
$174,200
$8.02 P/Share
|
|
Nov 04
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,459
-87.47%
|
$6,711,047
$133.79 P/Share
|
|
Nov 04
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,459
+46.66%
|
$403,672
$8.02 P/Share
|
|
Nov 03
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
91,705
-92.69%
|
$12,105,060
$132.34 P/Share
|
|
Nov 03
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
91,705
+48.1%
|
$733,640
$8.02 P/Share
|
|
Oct 08
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,774
-63.86%
|
$1,507,332
$118.84 P/Share
|
|
Oct 08
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,774
+38.97%
|
$102,192
$8.02 P/Share
|
|
Oct 07
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,390
-64.94%
|
$1,580,020
$118.77 P/Share
|
|
Oct 07
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,390
+39.37%
|
$107,120
$8.02 P/Share
|
|
Oct 06
2025
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,220
-72.67%
|
$2,306,400
$120.17 P/Share
|
|
Oct 06
2025
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,220
+42.09%
|
$153,760
$8.02 P/Share
|